Bio-Rad Laboratories Files 8-K for Regulation FD Disclosure
Ticker: BIO-B · Form: 8-K · Filed: Feb 21, 2025 · CIK: 12208
| Field | Detail |
|---|---|
| Company | Bio-Rad Laboratories, Inc. (BIO-B) |
| Form Type | 8-K |
| Filed Date | Feb 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, regulation-fd
Related Tickers: BIO
TL;DR
BIO filed an 8-K for a Reg FD disclosure, no new material info beyond that.
AI Summary
Bio-Rad Laboratories, Inc. filed an 8-K on February 21, 2025, to report a Regulation FD Disclosure. The filing does not contain specific financial figures or material events beyond the disclosure itself.
Why It Matters
This filing indicates Bio-Rad Laboratories is making a public disclosure under Regulation FD, ensuring all investors receive the same material information simultaneously.
Risk Assessment
Risk Level: low — The filing is a standard disclosure and does not report any new material events, financial results, or significant changes.
Key Players & Entities
- BIO-RAD LABORATORIES, INC. (company) — Registrant
- February 21, 2025 (date) — Date of Report
- 1000 Alfred Nobel Dr. Hercules , California 94547 (address) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure.
What is the exact date of the report for this 8-K filing?
The exact date of the report for this 8-K filing is February 21, 2025.
What is the company's exact name as specified in its charter?
The company's exact name is BIO-RAD LABORATORIES, INC.
In which state was Bio-Rad Laboratories, Inc. incorporated?
Bio-Rad Laboratories, Inc. was incorporated in Delaware.
What is the address of Bio-Rad Laboratories, Inc.'s principal executive offices?
The address of Bio-Rad Laboratories, Inc.'s principal executive offices is 1000 Alfred Nobel Dr. Hercules, California 94547.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 21, 2025 regarding BIO-RAD LABORATORIES, INC. (BIO-B).